SCHEMBL254475

SCHEMBL254475

COC(=O)[C@@H](NC=O)[C@](O)(CF)CSc1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
ALDH1A1 P00352 4/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 6/20 0.35
USP2 O75604 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15237907 0.84 TSHR (0.48) TSHRALDH1A1MAPK1HPGDUSP2
SCHEMBL255151 0.84 TSHR (0.44) TSHRALDH1A1MAPK1HPGDUSP2
SCHEMBL15235754 0.81 TSHR (0.42) TSHRALDH1A1MAPK1HPGDUSP2
SCHEMBL15235756 0.69 HPGD (0.40) ALDH1A1MAPK1HPGDUSP2NPC1
SCHEMBL15237905 0.69 TSHR (0.48) TSHR
SCHEMBL24863646 0.67 MLYCD (0.41) ALDH1A1MAPK1HPGDUSP2NPC1
SCHEMBL28023317 0.67 HPGD (0.48) ALDH1A1MAPK1HPGDUSP2NPC1
SCHEMBL15235761 0.65 PPARG (0.40) TSHRALDH1A1HPGDUSP2NPC1
SCHEMBL12240328 0.65 HPGD (0.49) ALDH1A1HPGDUSP2NPC1TP53
SCHEMBL28023324 0.65 HPGD (0.45) ALDH1A1MAPK1HPGDUSP2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349544-A1 Ethynylbenzene Derivatives DUKE UNIVERSITY 2017-12-07 US disclosed
US-9738604-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2017-08-22 US disclosed
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2013-09-05 US disclosed
WO-2012031298-A2 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349544-A1 Ethynylbenzene Derivatives Q6ZSR9, EPX, ZYX TSHR 1690/4885ALDH1A1 1651/4885MAPK1 3489/4885
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES Q6ZSR9, EPX, ZYX TSHR 1690/4885ALDH1A1 1651/4885MAPK1 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.